Home/Filings/4/0001055726-23-000001
4//SEC Filing

Shepard Jay 4

Accession 0001055726-23-000001

CIK 0001055726other

Filed

Jan 16, 7:00 PM ET

Accepted

Jan 17, 4:05 PM ET

Size

7.1 KB

Accession

0001055726-23-000001

Insider Transaction Report

Form 4
Period: 2023-01-15
Shepard Jay
Director
Transactions
  • Exercise/Conversion

    Restricted Stock Unit

    2023-01-154,2730 total
    Common Stock (4,273 underlying)
  • Exercise/Conversion

    Common Stock

    2023-01-15+4,27339,521 total
Footnotes (1)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 12,821 restricted stock units is as follows: 4,274 shares vested on January 15, 2021; 4,274 shares vested on January 15, 2022; 4,273 shares vested on January 15, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both

Issuer

INOVIO PHARMACEUTICALS, INC.

CIK 0001055726

Entity typeother

Related Parties

1
  • filerCIK 0001587788

Filing Metadata

Form type
4
Filed
Jan 16, 7:00 PM ET
Accepted
Jan 17, 4:05 PM ET
Size
7.1 KB